Aziz Mottiwala - 04 Nov 2021 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Chief Commercial Officer
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
04 Nov 2021
Net transactions value
-$3,112
Form type
4
Filing time
08 Nov 2021, 16:49:29 UTC
Previous filing
04 Nov 2021
Next filing
10 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale $2,803 -100 -0.19% $28.03 52,103 04 Nov 2021 Direct F1
transaction TARS Common Stock Sale $309 -11 -0.02% $28.11 52,092 05 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021.